Neuroinflammation is a fundamental driver of PD pathology [175], and GSK3β has been identified as critically involved in the regulation of PD-related cerebral inflammation, oxidative stress [176], and the expression of pathogenic proteins (e.g., α-synuclein) [177]. The gene discussed is GSK3B; the disease is Parkinson disease.